4509 POSTER Sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (mRCC): updated efficacy and safety results and further analysis of prognostic factors
2007 ◽
Vol 5
(4)
◽
pp. 301
◽
2008 ◽
Vol 7
(3)
◽
pp. 245
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 4609-4609
◽
Keyword(s):
2015 ◽
Vol 25
(5)
◽
pp. 395-401
◽
Keyword(s):